Goldman Sachs Group Inc Direxion Daily S&P Biotech Bea Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Direxion Daily S&P Biotech Bea stock. As of the latest transaction made, Goldman Sachs Group Inc holds 35,596 shares of LABD stock, worth $269,817. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,596
Previous 213,142
83.3%
Holding current value
$269,817
Previous $2.07 Million
87.46%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding LABD
# of Institutions
31Shares Held
3.24MCall Options Held
2MPut Options Held
402K-
Bank Of America Corp Charlotte, NC548KShares$4.16 Million0.0% of portfolio
-
Blue Owl Capital Holdings LP New York, NY490KShares$3.71 Million0.95% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA430KShares$3.26 Million0.0% of portfolio
-
Virtu Financial LLC New York, NY402KShares$3.04 Million0.22% of portfolio
-
Boxer Capital, LLC San Diego, CA350KShares$2.65 Million0.13% of portfolio